Indole Compounds Dual PPAR Activation for Lipid Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cardiovascular diseases and metabolic disorders, such as hyperlipidemia and hypercholesterolemia, often rely on statins and fibrates that target specific receptors, but there is a need for compounds that can activate both PPARα and PPARδ receptors simultaneously to effectively manage these conditions.
Innovation Solution
Development of novel indole compounds that act as PPAR activators, specifically designed to activate both PPARα and PPARδ receptors, which are synthesized through a multi-step process involving Sonogashira reaction, reduction, arylation, cyclization, and hydrolysis, and can be used in pharmaceutical compositions to treat hypercholesterolemia, hyperlipidemia, and related cardiovascular diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If compounds target only PPARα or PPARδ receptors individually, then the treatment mechanism is simpler, but the therapeutic effectiveness for managing hyperlipidemia and hypercholesterolemia is insufficient
Solution Approach 1:
The indole compound of formula (I) is designed to simultaneously activate both PPARα and PPARδ receptors, making a single compound perform multiple therapeutic functions. This dual activation addresses multiple aspects of lipid metabolism regulation, improving overall therapeutic effectiveness for cardiovascular diseases without requiring separate medications for each receptor type
Solution Approach 2:
The patent merges the activation of two separate receptor pathways (PPARα and PPARδ) into a single compound. By combining the pharmacological effects of PPARα activation (triglyceride reduction) and PPARδ activation (HDL cholesterol elevation) in one molecule, the treatment achieves comprehensive lipid management
2Adaptability or versatility
If existing treatments use separate medications for different lipid parameters, then each medication has a specific mechanism, but the overall treatment regimen becomes more complex
Solution Approach 1:
A single indole compound addresses multiple lipid parameters simultaneously by activating both PPARα (for triglyceride control) and PPARδ (for HDL cholesterol improvement). This versatile approach replaces the need for multiple specialized medications, simplifying the treatment regimen while maintaining comprehensive coverage
Solution Approach 2:
The treatment regimen is simplified by merging multiple therapeutic actions into one compound. Instead of prescribing separate medications for different lipid abnormalities, the dual-activating indole compound provides integrated treatment for hyperlipidemia and hypercholesterolemia
Data Source
AI summary
Indole compounds corresponding to the formula (I):as defined in the claims, pharmaceutically acceptable addition salts of such compounds, pharmaceutical compositions containing such compounds, the process for their preparation, and their use as pharmacologically active substances, especially in the treatment of hypertriglyceridemia, hyperlipidemia, hypercholesterolemia, diabetes, endothelial dysfunction, cardiovascular disease, inflammatory disease and neurodegeneration.